SPOTLIGHT -
The new keratoprosthesis, AlphaCor (Argus Biomedical Pty Ltd., Perth, Western Australia), while not the first of its kind, seems to be more user-friendly for corneal transplant surgeons than human tissue.
SalioGen Therapeutics taps development candidate for ABCA4-mediated Stargardt disease
(EyePod) From idea to impact: Navigating ophthalmic innovation
Ocular Therapeutix announces positive topline Phase 1 data for Axpaxli in diabetic retinopathy
EyePod: Modifier Gene Therapy: What is it?
Patients with dry eye suffer from worse sleep quality
Ophthalmic industry veteran Erin Schallhorn Powers joins Holland Foundation for Sight Restoration Board of Directors